Wexford Capital’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-33,307
Closed -$5.13M 261
2024
Q3
$5.13M Buy
33,307
+29,907
+880% +$4.53M 1.23% 20
2024
Q2
$496K Sell
3,400
-8,112
-70% -$1.16M 0.13% 111
2024
Q1
$1.7M Sell
11,512
-1,230
-10% -$176K 0.35% 58
2023
Q4
$1.74M Sell
12,742
-37,035
-74% -$4.82M 0.37% 58
2023
Q3
$6.41M Buy
+49,777
New +$6.61M 1.42% 16
2018
Q4
Sell
-35,776
Closed -$3.4M 157
2018
Q3
$3.4M Buy
+35,776
New +$3.23M 0.22% 51
2016
Q4
Sell
-96,222
Closed -$6.94M 316
2016
Q3
$6.94M Buy
+96,222
New +$7.08M 1.13% 26
2016
Q1
Sell
-665,362
Closed -$47.9M 109
2015
Q4
$47.9M Buy
+665,362
New +$47M 11.28% 1
2015
Q3
Sell
-154,481
Closed -$11.5M 100
2015
Q2
$11.5M Buy
154,481
+131,570
+574% +$9.75M 3.07% 6
2015
Q1
$1.66M Buy
+22,911
New +$1.63M 0.48% 35

Other funds holding XLV

Wexford Capital's XLV Position: Q4 2024 in Review

Wexford Capital sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2024, closing a stake of 33,307 shares — an estimated $5.13M sold.

Wexford Capital first reported a position in XLV in Q1 2015 and held it in 10 quarters. The position peaked at $47.9M in Q4 2015. 1,759 funds tracked by Wall St. Rank hold XLV as of Q4 2024.

  • Wexford Capital reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2024 after selling out during the quarter.
  • Wexford Capital sold 33,307 State Street Health Care Select Sector SPDR ETF shares in Q4 2024, an estimated $5.13M.
  • Wexford Capital first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2015 and held it in 10 quarters.
  • Wexford Capital's State Street Health Care Select Sector SPDR ETF position peaked at $47.9M in Q4 2015.
  • 1,759 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2024.

Based on Wexford Capital's 13F filing for Q4 2024, filed 14 Feb 2025.